Vericel Corp (NASDAQ:VCEL)

19.04
Delayed Data
As of Sep 18
 +0.06 / +0.32%
Today’s Change
6.78
Today|||52-Week Range
19.64
+9.43%
Year-to-Date
Vericel (VCEL) Investor Presentation - Slideshow
Sep 18 / Seeking Alpha - Paid Partner Content
MediWound: An Underfollowed Opportunity At A Discount
Sep 08 / Seeking Alpha - Paid Partner Content
FDA accepts MediWound/Vericel's NexoBrid application
Sep 16 / Seeking Alpha - Paid Partner Content
MediWound completes first NexoBrid delivery for $16.5M
Aug 25 / Seeking Alpha - Paid Partner Content

Today’s Trading

Previous close18.98
Today’s open19.16
Day’s range18.65 - 19.54
Volume45,058
Average volume (3 months)590,753
Market cap$717.7M
Data as of 3:59pm ET, 09/18/2020

Growth & Valuation

Earnings growth (last year)-8.21%
Earnings growth (this year)+21.97%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)+29.71%
P/E ratio1,904.0
Price/Sales6.52
Price/Book6.41

Competitors

 Today’s
change
Today’s
% change
CLLSCellectis SA+0.46+2.26%
PRVBProvention Bio Inc+0.39+2.63%
PETQPetIQ Inc-0.37-1.18%
KRYSKrystal Biotech Inc+2.12+4.58%
Data as of 3:59pm ET, 09/18/2020

Financials

Next reporting dateNovember 10, 2020
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$117.9M
Annual profit (last year)-$9.7M
Net profit margin-8.20%

Profile

Sector
Health Technology
Industry
Medical Specialties
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts